Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Net Cash Flow (2016 - 2025)

Marimed has reported Net Cash Flow over the past 14 years, most recently at $2.3 million for Q4 2025.

  • Quarterly Net Cash Flow rose 191.3% to $2.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.6 million through Dec 2025, up 121.76% year-over-year, with the annual reading at $1.6 million for FY2025, 121.76% up from the prior year.
  • Net Cash Flow was $2.3 million for Q4 2025 at Marimed, up from $458000.0 in the prior quarter.
  • Over five years, Net Cash Flow peaked at $11.9 million in Q1 2023 and troughed at -$25.6 million in Q2 2022.
  • The 5-year median for Net Cash Flow is $523500.0 (2024), against an average of $294250.0.
  • Year-over-year, Net Cash Flow skyrocketed 10605.47% in 2021 and then crashed 607.26% in 2022.
  • A 5-year view of Net Cash Flow shows it stood at $4.1 million in 2021, then crashed by 133.54% to -$1.4 million in 2022, then soared by 200.73% to $1.4 million in 2023, then plummeted by 280.81% to -$2.5 million in 2024, then soared by 191.3% to $2.3 million in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Net Cash Flow are $2.3 million (Q4 2025), $458000.0 (Q3 2025), and -$1.1 million (Q2 2025).